Skip to main content
Sign In

  

Contact Info:

Pulmonary Sciences & Critical Care Medicine

University Colorado Denver - Anschutz Medical Campus Research Building 2, 9th Floor12700 E. 19th Ave Aurora, Colorado 80045

​Follow Us

facebook-logo.pngtwitter-logo.png

​​​​​​​​​​​​

​Give Online

 

Call for Abstracts

Abstract Deadline:   February 14, 2018​

Dear Colleagues:
On June 6-9, 2018 the 61st Annual Thomas L. Petty Aspen Lung Conference will convene at The Gant Conference Center in Aspen, Colorado.   The theme of the conference will be “Translating Resilience and Pathogenesis to Personalized Therapy for COPD”.  Chronic obstructive pulmonary disease (COPD) is the 3rd leading cause of death in the United States and the 4th leading cause of death worldwide.  Despite progress, current therapies only mitigate symptoms and have no clear effect on mortality or the long-term decline in lung function. Understanding the pathophysiology of COPD, developing novel treatment strategies, and effectively implementing lung-reparative therapeutics would be expected to have significant impact on COPD, as well as other pulmonary diseases.  With an emphasis on the integration of basic, translational and clinical approaches, the 61st Annual Thomas L. Petty Aspen Lung Conference will focus on a central question: how can knowledge of resilience or susceptibility to develop COPD be translated into more effective therapies?  To address this central question, we have organized the program into a series of thematic sessions that will be framed by a Keynote Address, Clinical Perspective and NHLBI Perspective. The thematic sessions will focus on (i) clinical and molecular heterogeneity of COPD,  (ii) COPD as a disease of accelerated aging, (iii) stem cell dysfunction and regenerative therapies for COPD, (iv) immune and epithelial cell mechanisms of COPD exacerbations, (v) metabolic and biochemical mechanisms of COPD pathogenesis, and (vi) consequences of COPD beyond the obstructed lung. These thematic sessions will be anchored by state-of-the-art presentations from thought leaders in each respective area, with ample time dedicated to scientific debate.  Finally, the varied scientific themes and therapeutic strategies emerging during the conference will be reconciled in a concluding Conference Summary presented by Stephen I. Rennard, M.D., Professor of Medicine, University of  Nebraska and Head, Clinical Discovery Unit, AstraZeneca. 

As with previous Aspen Lung Conferences, we will utilize the successful format of State of the Art presentations grouped with relevant, short presentations.  Each presentation will have sufficient time for discussion to facilitate a lively exchange of new ideas and thoughts on COPD. There will be seven honorary lectures:  the Parker B. Francis Lectureship, the Roger S. Mitchell Lecture, the Giles F. Filley Lecture, the Thomas A. Neff Lecture, the Reuben M. Cherniack Lecture, the Thomas L. Petty Lecture and the Marvin I. Schwarz Lecture. 

We are particularly interested in attracting translational basic or clinical research abstracts related to the broad topics above.  Accordingly, we invite you and your colleagues to submit abstracts for consideration for a podium presentation and/or a poster at the conference (abstracts can be similar to those used for ATS).  Please follow the instructions on the Aspen Lung Conference Website www.aspenlungconference.org (click) Call for Abstracts. The deadline for abstract submission is February 14, 2018.  All who submit abstracts are invited to attend the conference whether their abstract is accepted or not but must register if they plan to attend.  Time limitations, however, do not allow all submitted abstracts to be presented.  In the past, about one third of the submitted abstracts were accepted for podium presentations or poster sessions based on evaluation by a Selection Committee.  We will offer two Thomas L. Petty Fellow Travel Awards in the amount of $1,000 each to two fellows whose abstracts have been accepted for podium presentations.  All investigators will be notified on or near March 31, 2018 about acceptance of their abstracts.  Additionally, please register if you wish to attend, even if you do not plan to submit an abstract, as we expect a large turnout. 

On behalf of our Co-Chair, Moumita Ghosh, Ph.D., we look forward to your participation in the Thomas L. Petty Aspen Lung Conference, 61st Annual Meeting and to a combination of outstanding science and great fun.  We hope that you and your colleagues will be able to join us. For additional information about this important conference please visit www.aspenlungconference.org 

Sincerely yours,

Irina Petrache, M.D.
Chair, 61st Annual Meeting                                                        
Thomas L. Petty Aspen Lung Conference
Professor, Wollowick Chair in COPD Research
National Jewish Health
Professor, University of Colorado, Denver
Denver, Colorado, USA

R. William Vandivier, M.D.
Chair, 61st Annual Meeting
Thomas L. Petty Aspen Lung Conference
Professor of Medicine
Division of Pulmonary Sciences and Critical Care Medicine
Director, COPD Program
University of Colorado School of Medicine
Aurora, Colorado, USA